Aarti Pharmalabs Ltd. - Research Center
543748 AARTIPHARM Group (A) BSE data
Add to watchlist
| Results |
Quarterly
|
| Statement | |
| More |
Quarterly results in brief
(Rs crore)
| Sep' 24 | Jun' 24 | Mar' 24 | Dec' 23 | Sep' 23 | |
|---|---|---|---|---|---|
| Sales | 377.29 | 393.49 | 414.82 | 373.03 | 356.14 |
| Operating profit | 84.77 | 83.65 | 107.33 | 88.27 | 73.81 |
| Interest | 5.39 | 4.25 | 4.42 | 4.10 | 3.82 |
| Gross profit | 82.33 | 81.52 | 108.60 | 84.37 | 69.99 |
| EPS (Rs) | 5.28 | 5.20 | 6.95 | 5.32 | 4.61 |
Quarterly
results in details
| Sep' 24 | Jun' 24 | Mar' 24 | Dec' 23 | Sep' 23 | |
|---|---|---|---|---|---|
| Other income | 2.95 | 2.11 | 5.69 | 0.20 | - |
| Stock adjustment | -36.56 | 10.09 | 7.36 | -5.32 | -6.11 |
| Raw material | 196.38 | 191.41 | 179.69 | 191.11 | 196.88 |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 35.47 | 37.01 | 34.67 | 34.29 | 29.84 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 97.23 | 71.32 | 85.77 | 64.68 | 61.72 |
| Provisions made | - | - | - | - | - |
| Depreciation | 18.89 | 18.29 | 17.32 | 16.94 | 16.32 |
| Taxation | 15.60 | 16.08 | 28.26 | 19.25 | 11.86 |
| Net profit / loss | 47.84 | 47.14 | 63.02 | 48.19 | 41.81 |
| Extra ordinary item | - | - | - | - | - |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 45.31 | 45.31 | 45.31 | 45.31 | 45.31 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | - | - | - | - | - |
| Agg.of non promotoholding (%) | - | - | - | - | - |
| OPM (%) | 22.47 | 21.26 | 25.87 | 23.66 | 20.72 |
| GPM (%) | 21.65 | 20.61 | 25.83 | 22.61 | - |
| NPM (%) | 12.58 | 11.92 | 14.99 | 12.91 | - |
© 2025 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis